Retatrutide and tirzepatide are not the same medicine. Tirzepatide activates two hormone receptors—GIP and GLP-1—and is FDA approved for specific uses. Retatrutide activates GIP, GLP-1 and glucagon receptors and remains investigational. Although separate…